1. Home
  2. SUPN vs FUL Comparison

SUPN vs FUL Comparison

Compare SUPN & FUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

N/A

Current Price

$29.57

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Logo H. B. Fuller Company

FUL

H. B. Fuller Company

N/A

Current Price

$49.49

Market Cap

2.7B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SUPN
FUL
Founded
2005
1887
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.7B
IPO Year
2014
2008

Fundamental Metrics

Financial Performance
Metric
SUPN
FUL
Price
$29.57
$49.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
7
Target Price
$54.14
★ $66.29
AVG Volume (30 Days)
★ 2.4M
521.1K
Earning Date
10-29-2026
09-23-2026
Dividend Yield
N/A
★ 1.98%
EPS Growth
★ 8100.00
19.57
EPS
2.78
★ 3.05
Revenue
$1,239,000,000.00
★ $2,897,000,000.00
Revenue This Year
$51.56
$3.80
Revenue Next Year
$30.35
$7.22
P/E Ratio
★ $10.65
$16.29
Revenue Growth
★ 4.29
N/A
52 Week Low
$25.92
$46.70
52 Week High
$59.68
$68.63

Technical Indicators

Market Signals
Indicator
SUPN
FUL
Relative Strength Index (RSI) 31.65 44.45
Support Level $25.92 $48.66
Resistance Level $51.59 $53.26
Average True Range (ATR) 2.00 1.51
MACD -0.52 -0.01
Stochastic Oscillator 19.96 18.33

Price Performance

Historical Comparison
SUPN
FUL

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About FUL H. B. Fuller Company

H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. It generates the maximum revenue from hygiene, health, and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven, and hygiene (disposable diapers, feminine care, and medical garments) and health and beauty. The company generates around half of its revenue in the United States.

Share on Social Networks: